HCC
Hirtle Callaghan & Co’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.59M | Sell |
41,029
-6,368
| -13% | -$402K | 0.1% | 42 |
|
2025
Q1 | $2.61M | Buy |
47,397
+6,043
| +15% | +$333K | 0.1% | 43 |
|
2024
Q4 | $2.29M | Hold |
41,354
| – | – | 0.1% | 51 |
|
2024
Q3 | $2.53M | Buy |
41,354
+16
| +0% | +$978 | 0.1% | 47 |
|
2024
Q2 | $2.45M | Sell |
41,338
-144,933
| -78% | -$8.58M | 0.11% | 45 |
|
2024
Q1 | $10.7M | Buy |
186,271
+141,000
| +311% | +$8.12M | 0.46% | 28 |
|
2023
Q4 | $2.51M | Hold |
45,271
| – | – | 0.11% | 43 |
|
2023
Q3 | $2.26M | Hold |
45,271
| – | – | 0.11% | 44 |
|
2023
Q2 | $2.35M | Buy |
45,271
+358
| +0.8% | +$18.6K | 0.11% | 43 |
|
2023
Q1 | $2.22M | Buy |
+44,913
| New | +$2.22M | 0.11% | 42 |
|
2022
Q2 | – | Sell |
-3,645
| Closed | -$212K | – | 131 |
|
2022
Q1 | $212K | Buy |
+3,645
| New | +$212K | 0.01% | 126 |
|